newsfilter
← Latest News
GlobeNewswire·

Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference

CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that...